Dec 16, 2021 · Merck and Ridgeback Announce Publication of Phase 3 Study of Molnupiravir, Oral Antiviral COVID-19 Treatment, in the New England Journal of Medicine
02.06.2018 · Fecal Microbiota for Clostridium difficile Clostridium difficile is the leading cause of nosocomial infectious diarrhea. New treatment strategies are …
The New England Journal of Medicine, Waltham, Massachusetts. 1,823,253 likes · 5,225 talking about this · 4,133 were here. The New England Journal of Medicine (NEJM.org) is the world's leading...
Original Article from The New England Journal of Medicine — Long-Term Colorectal-Cancer Mortality after Adenoma ... (to Drs. Løberg and Holme), and the …
The New England Journal of Medicine (NEJM) is today the highest ranked general medical journal. It is unknown if there exists institutional bias favoring ...
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
15.04.2021 · Det skriver Klassekampen torsdag.. Fredag forrige uke publiserte medisintidsskriftet New England Journal of Medicine (NEJM) en fagartikkel …
09.04.2021 · Summary We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine ag...
The New England Journal of Medicine. The New England Journal of Medicine ( NEJM) is a weekly medical journal published by the Massachusetts Medical Society. It is among the most prestigious peer-reviewed medical journals as well as the oldest continuously published one.
13.01.2021 · A collection of resources on Covid-19 vaccines, including published research, continuing medical education, and commentary. See also the NEJM Coronavirus (Covid-19) page. To realize the potential ...
10.04.2021 · Fredag ettermiddag ble saken publisert i The New England Journal of Medicine. Samtidig ble også en tilsvarende tysk studie med samme funn publisert. Begge slår fast at det er sammenheng mellom AstraZenecas koronavaksine og faren for alvorlige bivirkninger.
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
15.04.2021 · Artikkelen sto i prestisjetunge New England Journal of Medicine (NEJM) og fikk mye internasjonal oppmerksomhet. Den konkluderte med at blodpropp av typen som tok livet av tre helsearbeidere, skyldes Astrazeneca-vaksinen. Holme jobber ved avdeling for blodsykdommer ved Oslo Universitetssykehus.
Sep 02, 2020 · The New England Journal of Medicine has published pivotal AMX0035 data demonstrating statistically significant benefit in people with ALS.
Jan 12, 2022 · The overall effectiveness of the BNT162b2 vaccine against hospitalization for Covid-19 was 94% (95% confidence interval [CI], 90 to 96); the effectiveness was 95% (95% CI, 91 to 97) among test ...
... M.D., Ph.D.,; and Pål A. Holme, M.D., Ph.D. et al. June 3, 2021. N Engl J Med 2021; 384:2124-2130. DOI: 10.1056/NEJMoa2104882. Article; Figures/Media.
16.04.2021 · Artikkelen ble publisert i medisintidsskriftet New England Journal of Medicine fredag i forrige uke. Men Holme har mottatt over 1 million kroner fra konkurrentene Pfizer og Bayer de siste fem årene, skrev Klassekampen onsdag. I en epost til NRK og nettavisen Børsen torsdag skriver Holme at han burde opplyst om honorarene.